CHAMPIONS ONCOLOGY, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures
CHAMPIONS ONCOLOGY, INC. (CSBR) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures of 310.00 thousand shares for the 3-month period ending 2013-07-31, per its 10-Q filed 2013-09-13.
Discontinued › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod · last filed 2013-09-13
- CHAMPIONS ONCOLOGY, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2013-07-31 was 310.00K shares, a 23.38% increase year-over-year.
- CHAMPIONS ONCOLOGY, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2013-04-30 was 25.00K shares.
- CHAMPIONS ONCOLOGY, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2013-01-31 was 425.00K shares.
- CHAMPIONS ONCOLOGY, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2012-10-31 was 40.00K shares.
- CHAMPIONS ONCOLOGY, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2013 was 741.25K shares, a 50.42% decline from fiscal 2012.
- CHAMPIONS ONCOLOGY, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2012 was 1.50M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 12 month |
|---|---|---|---|---|
| 2013-07-31 | 310.00K shares 10-Q · filed 2013-09-13 | 335.00K shares derived: sum of 2 quarters · filed 2013-09-13 | 760.00K shares derived: sum of 3 quarters · filed 2013-09-13 | 800.00K shares derived: sum of 4 quarters · filed 2013-09-13 |
| 2013-04-30 | 25.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-26 | 450.00K shares derived: sum of 2 quarters · filed 2013-07-26 | 490.00K shares derived: sum of 3 quarters · filed 2013-07-26 | 741.25K shares 10-K · filed 2013-07-26 |
| 2013-01-31 | 425.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-03-13 | 465.00K shares derived: sum of 2 quarters · filed 2013-03-13 | 716.25K shares 10-Q · filed 2013-03-13 | |
| 2012-10-31 | 40.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2012-12-13 | 291.25K shares 10-Q · filed 2012-12-13 | ||
| 2012-07-31 | 251.25K shares 10-Q · filed 2012-09-12 | |||
| 2012-04-30 | 1.50M shares 10-K · filed 2013-07-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |